Can you provide a concise reference card showing the dosage, infusion rates, titration guidelines, and clinical uses for nitroglycerin (NTG), norepinephrine (noradrenaline), dobutamine, sodium nitroprusside, and adrenaline (epinephrine) infusions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Critical Care Vasopressor & Vasodilator Infusion Reference Card

NITROGLYCERIN (NTG)

Dosing & Titration

  • Starting dose: 10-20 mcg/min IV 1, 2
  • Titration: Increase by 5-10 mcg/min every 3-5 minutes 1
  • If no response at 20 mcg/min: Use increments of 10-20 mcg/min 1
  • Maximum dose: 200 mcg/min (commonly used ceiling; up to 400 mcg/min reported) 1, 3
  • Preparation: 50 mg in 500 mL = 100 mcg/mL concentration 3

Clinical Uses

  • Acute coronary syndromes with ongoing ischemia 1
  • Acute heart failure with SBP >110 mmHg 2
  • Hypertensive emergencies 4
  • Pulmonary edema (preload reduction) 4

Critical Precautions

  • **Avoid if SBP <90 mmHg** or >30 mmHg below baseline 1
  • Contraindicated within 24h of sildenafil, 48h of tadalafil (risk of profound hypotension/death) 1
  • Target SBP ≥110 mmHg in normotensive patients 1
  • Tolerance develops after 24-48 hours 1, 2
  • Use non-absorbing tubing (PVC absorbs drug) 3

SODIUM NITROPRUSSIDE

Dosing & Titration

  • Starting dose: 0.3 mcg/kg/min IV 2
  • Titration: Increase by 0.5 mcg/kg/min every 5 minutes 2
  • Maximum dose: 5-10 mcg/kg/min 2
  • Arterial line recommended for BP monitoring 2

Clinical Uses

  • Acute heart failure with severe afterload excess 2
  • Hypertensive emergencies (balanced vasodilator) 4
  • Acute aortic dissection (combined with beta-blocker) 4
  • Cardiogenic pulmonary edema 4

Critical Precautions

  • Risk of abrupt hypotension (especially in ACS patients) 2
  • Cyanide/thiocyanate toxicity with prolonged use or high doses 4
  • Avoid in liver/kidney failure (relative contraindication) 4
  • Use cautiously in acute coronary syndromes 2
  • Protect from light 3

NOREPINEPHRINE (NORADRENALINE)

Dosing & Titration

  • Starting dose: 0.2-1.0 mcg/kg/min (or 0.05-0.5 mcg/kg/min) 2, 5
  • Typical range: 0.5-30 mcg/min (non-weight-based) 6
  • Titration: Adjust every 2-5 minutes to MAP goal
  • No maximum dose established (clinical practice varies widely: 20-400 mcg/min reported) 7

Clinical Uses

  • Septic shock with hypotension 8
  • Cardiogenic shock refractory to other agents 2, 5
  • Right heart failure (improves coronary perfusion pressure) 8
  • Profound hypotension after multiple epinephrine doses 6

Critical Precautions

  • Risk of tissue necrosis with extravasation 5
  • Increases myocardial oxygen demand 8
  • May worsen pulmonary edema if used alone in left heart failure 8
  • Caution with MAO inhibitors 5

DOBUTAMINE

Dosing & Titration

  • Starting dose: 2-2.5 mcg/kg/min IV 2, 9
  • Titration: Double dose every 15 minutes based on response 10
  • Usual range: 2-20 mcg/kg/min 2, 5, 9
  • Maximum: Rarely >20 mcg/kg/min (up to 40 mcg/kg/min reported) 9
  • No bolus dose 2

Clinical Uses

  • Low cardiac output states with adequate BP 2, 5
  • Acute heart failure with hypoperfusion 2, 10
  • Bridge to mechanical support or transplant 5
  • Cardiogenic shock (often combined with vasodilator) 8, 11

Critical Precautions

  • Use cautiously if HR >100 bpm (risk of tachycardia/arrhythmias) 2
  • May cause hypotension (mild beta-2 vasodilation) 10, 5
  • Increases myocardial oxygen demand 5
  • Do NOT mix with sodium bicarbonate or alkaline solutions 9
  • Stable for 24 hours after dilution 9

EPINEPHRINE (ADRENALINE)

Dosing & Titration

For Anaphylaxis:

  • IM injection (first-line): 0.3-0.5 mg (1:1000) in lateral thigh, repeat every 5 minutes 6
  • IV infusion (refractory cases only):
    • Preparation: 1 mg in 250 mL D5W = 4 mcg/mL 6
    • Rate: 1-4 mcg/min (15-60 drops/min), max 10 mcg/min 6
    • Alternative: 1 mg in 100 mL saline, infuse 30-100 mL/h (5-15 mcg/min) 6

For Cardiogenic Shock:

  • Infusion: 0.05-0.5 mcg/kg/min 2, 5
  • Cardiac arrest bolus: 1 mg IV every 3-5 minutes 2

Clinical Uses

  • Anaphylaxis (IM preferred) 6
  • Cardiac arrest 2
  • Profound hypotension/cardiogenic shock 2, 5
  • Acute left heart failure (combined with vasodilator) 8, 12

Critical Precautions

  • IV route ONLY for cardiac arrest or profound hypotension after failed IM doses and volume resuscitation 6
  • Risk of lethal arrhythmias with IV administration 6
  • Requires continuous hemodynamic monitoring if given IV 6
  • Increases myocardial oxygen demand significantly 5
  • Caution with MAO inhibitors 5

KEY CLINICAL PEARLS

Blood Pressure Targets

  • NTG/Nitroprusside: Maintain SBP ≥110 mmHg or ≤25% reduction from baseline 1, 2
  • Vasopressors: Target MAP ≥65 mmHg (individualize based on organ perfusion)

Combination Therapy

  • Dobutamine + NTG/Nitroprusside: Effective for acute heart failure with hypertension 8, 11, 12
  • Epinephrine + NTG: Reduces PAWP elevation while maintaining inotropy 12
  • Beta-blocker + Nitroprusside: Essential for acute aortic dissection 4

Common Pitfalls

  • NTG tolerance: Develops after 24-48h; may need dose escalation or nitrate-free intervals 1
  • PVC tubing absorption: Use non-absorbing tubing for NTG (reduces required dose) 3
  • Nitroprusside in ACS: Use cautiously due to coronary steal phenomenon 2
  • IV epinephrine: Reserve for true emergencies; IM route safer for anaphylaxis 6

References

Guideline

esc council on hypertension position document on the management of hypertensive emergencies.

European Heart Journal - Cardiovascular Pharmacotherapy, 2019

Guideline

the diagnosis and management of anaphylaxis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2005

Research

[The basics of catecholamine therapy. 2. A guide to clinical use].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2000

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.